Practical Laboratory Tools for Monitoring of BCR-ABL1 Transcripts and Tyrosine Kinase (TK) Domain Mutations in Chronic Myeloid Leukemia Patients Undergoing TK Inhibitor Therapy: A Single-Center Experience in Thailand

OBJECTIVE: The genetic hallmark of CML is known as the appearance of t(9;22)(q34.1;q11.2) (BCR-ABL1) which is present in more than 95% of cases. Here, we demonstrated practical laboratory tools for monitoring of BCR-ABL1 transcripts in chronic myeloid leukemia patients undergoing TK inhibitor therap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Asian Pac J Cancer Prev
Autors principals: Limsuwanachot, Nittaya, Kongruang, Adcharee, Rerkamnuaychoke, Budsaba, Singdong, Roongrudee, Niparuck, Pimjai, Jootar, Saengsuree, Siriboonpiputtana, Teerapong
Format: Artigo
Idioma:Inglês
Publicat: West Asia Organization for Cancer Prevention 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7573403/
https://ncbi.nlm.nih.gov/pubmed/32711426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.7.2003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars